Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects

PHASE1UnknownINTERVENTIONAL

Enrollment

268

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

September 30, 2023

Conditions

Healthy Subjects

Interventions

BIOLOGICAL

CT-P47

CT-P47, 162 mg in 0.9 mL, a single subcutaneous (SC) injection via auto-injector (AI)

BIOLOGICAL

CT-P47

CT-P47, 162 mg in 0.9 mL, a single subcutaneous (SC) injection via pre-filled syringe (PFS)

Trial Locations (1)

RECRUITING

Seoul National University Hospital, Seoul